Your browser doesn't support javascript.
loading
Loss of Ambra1 promotes melanoma growth and invasion.
Di Leo, Luca; Bodemeyer, Valérie; Bosisio, Francesca M; Claps, Giuseppina; Carretta, Marco; Rizza, Salvatore; Faienza, Fiorella; Frias, Alex; Khan, Shawez; Bordi, Matteo; Pacheco, Maria P; Di Martino, Julie; Bravo-Cordero, Jose J; Daniel, Colin J; Sears, Rosalie C; Donia, Marco; Madsen, Daniel H; Guldberg, Per; Filomeni, Giuseppe; Sauter, Thomas; Robert, Caroline; De Zio, Daniela; Cecconi, Francesco.
Afiliação
  • Di Leo L; Melanoma Research Team, Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Bodemeyer V; Melanoma Research Team, Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Bosisio FM; Lab of Translational Cell and Tissue Research, University of Leuven, Leuven, Belgium.
  • Claps G; INSERM U981, Gustave Roussy Institute, Villejuif, France.
  • Carretta M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Rizza S; Redox Biology Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Faienza F; Department of Biology, University of Rome Tor Vergata, Rome, Italy.
  • Frias A; Melanoma Research Team, Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Khan S; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Bordi M; Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy.
  • Pacheco MP; Life Sciences Research Unit, University of Luxembourg, Belvaux, Luxembourg.
  • Di Martino J; School of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bravo-Cordero JJ; School of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Daniel CJ; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
  • Sears RC; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
  • Donia M; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Madsen DH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Guldberg P; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Filomeni G; Molecular Diagnostics Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Sauter T; Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Robert C; Redox Biology Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • De Zio D; Department of Biology, University of Rome Tor Vergata, Rome, Italy.
  • Cecconi F; Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark.
Nat Commun ; 12(1): 2550, 2021 05 05.
Article em En | MEDLINE | ID: mdl-33953176
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article